ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach [Yahoo! Finance]
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
Carl Zeiss Meditec AG (OTCMKTS: CZMWY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "buy" rating.